Commentary on Wang et al., "Pre-operative chemotherapy with oral tegafur-uracil and leucovorin for rectal cancer" (J Surg Oncol 89: 256-263)

J Surg Oncol. 2005 May 1;90(2):106-7. doi: 10.1002/jso.20262.
No abstract available

Publication types

  • Comment
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Clinical Trials, Phase II as Topic
  • Combined Modality Therapy
  • Disease-Free Survival
  • Drug Combinations
  • Female
  • Fluorouracil / chemistry
  • Humans
  • Leucovorin / administration & dosage
  • Male
  • Middle Aged
  • Preoperative Care*
  • Rectal Neoplasms / drug therapy*
  • Rectal Neoplasms / mortality
  • Rectal Neoplasms / radiotherapy*
  • Rectal Neoplasms / surgery
  • Survival Rate
  • Tegafur / administration & dosage
  • Uracil / administration & dosage

Substances

  • Drug Combinations
  • UFT(R) drug
  • Tegafur
  • Uracil
  • Leucovorin
  • Fluorouracil